Stock Rich List
#6640 on the rich list of 14,452 insiders

Mark G. Foletta

Director at DexCom; Director at AMN Healthcare Services. Based in San Diego, California.

$14.5M
in disclosed stock, −$509K (−3.40%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
6640th of 14,452
Companies held
2
Largest holding
DXCM, 90.6% of total
Latest SEC filing
Aug 3, 2026

What the $14.5M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
DexCom DXCM
Common Stock
Indirectly (see filing footnote)56,852$80.19$4.6M31.5%Form 4, May 8, 2026
DexCom DXCM
Common Stock
Through Trust51,316$80.19$4.1M28.5%Form 4, Aug 15, 2025
DexCom DXCM
Common Stock
Through Trust48,852$80.19$3.9M27.1%Form 4, Aug 3, 2026
AMN Healthcare Services AMN
Common Stock
Directly21,598$34.35$742K5.1%Form 4, May 1, 2026
AMN Healthcare Services AMN
Common Stock
Through Trust17,917$34.35$615K4.3%Form 4, Jun 15, 2026
DexCom DXCM
Common Stock
Directly6,331$80.19$508K3.5%Form 4, Jul 31, 2026

Share counts are the amounts Mark G. Foletta reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Aug 3, 2026SoldDXCM2,000$85.32$171KView
Jul 31, 2026SoldDXCM2,000$80.00$160KView
Jun 15, 2026SoldDXCM199$74.82$15KView
Jun 15, 2026SoldDXCM3,801$74.10$282KView
Jun 15, 2026SoldAMN1,681$31.07$52KView
Jun 15, 2026SoldAMN2,000$31.07$62KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
6637Peter Z. E. Vanacker
Chief Executive Officer, LyondellBasell Industries
$14.5M−$67K (−0.46%)
6638Matthew K. Fawcett
EVP, GC & Secretary, NetApp. Ashburn, VA
$14.5M−$400K (−2.69%)
6639Huntley Garriott
President, Live Oak Bank, Live Oak Bancshares. Wilmington, NC
$14.5M−$455K (−3.05%)
6640Mark G. Foletta
Director, DexCom. San Diego, CA
$14.5M−$509K (−3.40%)
6641Duston Williams
Chief Financial Officer, Nutanix. San Jose, CA
$14.5M−$30K (−0.21%)
6642Richard E. Perlman
Director, Onterris. North Little Rock, AR
$14.4M−$353K (−2.38%)
6643Robert I. Blum
President & CEO, Cytokinetics. South San Francisco, CA
$14.4M+$39K (+0.27%)

Other DexCom insiders

All DXCM insiders

Questions

How much stock does Mark G. Foletta own?

Mark G. Foletta holds $14,456,457 in listed stock based on SEC filings and current prices, mostly DexCom (DXCM). That ranks 6640th on the Stock Rich List.

Is this Mark G. Foletta's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Mark G. Foletta last buy or sell stock?

The most recent open-market trade on file is a sale of 2,000 DXCM shares on Aug 3, 2026 at $85.32.